Nature Communications (Mar 2018)

Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance

  • Melissa A. Meyer,
  • John M. Baer,
  • Brett L. Knolhoff,
  • Timothy M. Nywening,
  • Roheena Z. Panni,
  • Xinming Su,
  • Katherine N. Weilbaecher,
  • William G. Hawkins,
  • Cynthia Ma,
  • Ryan C. Fields,
  • David C. Linehan,
  • Grant A. Challen,
  • Roberta Faccio,
  • Rebecca L. Aft,
  • David G. DeNardo

DOI
https://doi.org/10.1038/s41467-018-03600-6
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 19

Abstract

Read online

Tumors escape the immune system through many mechanisms. Here the authors show that certain tumors inhibit anti-tumor immunity by stopping the production of conventional dendritic cells (cDCs) in the bone marrow, therefore depleting the pool of cDCs available to present antigen to CD8+ T cells.